Related references
Note: Only part of the references are listed.Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding
Jun Arai et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphoma
Dashnamoorthy Ravi et al.
LEUKEMIA (2020)
Challenges in liver cancer and possible treatment approaches
David Anwanwan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma
Jian Wang et al.
BIOMOLECULES (2020)
Bufalin down-regulates Axl expression to inhibit cell proliferation and induce apoptosis in non-small-cell lung cancer cells
Nam-Yi Kim et al.
BIOSCIENCE REPORTS (2020)
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
Ombretta Melaiu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Bufalin Induces Glioma Cell Death by Apoptosis or Necroptosis
Hai Rui LingHu et al.
OncoTargets and Therapy (2020)
Inhibition of MICA and MICB Shedding Elicits NK-Cell-Mediated Immunity against Tumors Resistant to Cytotoxic T Cells
Lucas Ferrari de Andrade et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma
Jian-Ping Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Bufalin exerts antitumor effects in neuroblastoma via the induction of reactive oxygen species-mediated apoptosis by targeting the electron transport chain
Lijia Pan et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)
An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma
Stefania Mantovani et al.
CANCERS (2020)
The NKG2D axis: an emerging target in cancer immunotherapy
Mariya Lazarova et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Nathalie Ganne-Carrie et al.
JOURNAL OF HEPATOLOGY (2019)
Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment
Tristan Courau et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
Chien-shan Cheng et al.
CANCER CELL INTERNATIONAL (2019)
Killers 2.0: NK cell therapies at the forefront of cancer control
Jonathan J. Hodgins et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Bufalin induces protective autophagy by Cbl-b regulating mTOR and ERK signaling pathways in gastric cancer cells
Hai-Yan Qi et al.
CELL BIOLOGY INTERNATIONAL (2019)
Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People
Yuanjie Pang et al.
HEPATOLOGY (2018)
Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide
Delphine Maucort-Boulch et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Immune checkpoint therapy in liver cancer
Feng Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Predominance of regorafenib over sorafenib: Restoration of membrane-bound MICA in hepatocellular carcinoma cells
Jun Arai et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity
Lucas Ferrari de Andrade et al.
SCIENCE (2018)
Liver Resection and Surgical Strategies for Management of Primary Liver Cancer
Sonia T. Orcutt et al.
CANCER CONTROL (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Combination of Cinobufacini and Doxorubicin Increases Apoptosis of Hepatocellular Carcinoma Cells through the Fas- and Mitochondria-Mediated Pathways
Jufeng Xia et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2017)
New knowledge of the mechanisms of sorafenib resistance in liver cancer
Yan-jing Zhu et al.
ACTA PHARMACOLOGICA SINICA (2017)
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
Andrea Marengo et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Bufalin enhances anti-angiogenic effect of sorafenib via AKT/VEGF signaling
Haiyong Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Liver cancer stem cell markers: Progression and therapeutic implications
Jing-Hui Sun et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway
Haiyong Wang et al.
ONCOTARGET (2016)
T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules
Jamie Rossjohn et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system
Kichang Han et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma
Liang Fang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice
Zhou-Ji Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells
Wei Gu et al.
ONCOLOGY REPORTS (2014)
Human NK Cell Receptors/Markers: A Tool to Analyze NK Cell Development, Subsets and Function
Elisa Montaldo et al.
CYTOMETRY PART A (2013)
Anticancer Effects of Bufalin on Human Hepatocellular Carcinoma HepG2 Cells: Roles of Apoptosis and Autophagy
Qing Miao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Bufalin Induces Lung Cancer Cell Apoptosis via the Inhibition of PI3K/Akt Pathway
Zhitu Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways
Fanghua Qi et al.
CANCER SCIENCE (2011)
Liver cancer epidemic in China: Past, present and future
Jian Guo Chen et al.
SEMINARS IN CANCER BIOLOGY (2011)
Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma
Keisuke Kohga et al.
JOURNAL OF HEPATOLOGY (2010)
Pilot Study of Huachansu in Patients With Hepatocellular Carcinoma, Nonsmall-Cell Lung Cancer, or Pancreatic Cancer
Zhiqiang Meng et al.
CANCER (2009)
Anticancer Chemotherapy Inhibits MHC Class I-Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma
Keisuke Kohga et al.
CANCER RESEARCH (2009)
The effects of telocinobufagin isolated from Chan Su on the activation and cytokine secretion of immunocytes in vitro
Yongguo Cao et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2009)
Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid
M Jinushi et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Share Paper
